ライフサイエンスコーパス: GGO

1 GGO (57 [90%] patients) and reticulation (62 [98%] patie

2 GGO onset was earlier and resolved later than consolidat

3 GGO was more frequently observed in patients with lympha

4 GGOs and consolidations corresponded with mixed histopat

5 GGOs and consolidations represented the main baseline lu

6 ing right and left lower lobe abnormalities, GGOs, and interlobular septal thickening.

7 idation of greater than or equal to 1.8% and GGO of greater than or equal to 13.5%.

8 ILST and GGO without crazy-paving were seen in 17% and 14.7%, res

9 HSA chromosome 11 and its equivalent PTR and GGO chromosomes.

10 have occurred at a period when both PTR and GGO had branched off from the Hominoidae trunk.

11 These pericentric inversions in PTR and GGO may have occurred at a period when both PTR and GGO

12 the HSA chromosome 12 equivalent in PTR and GGO, but was not seen in HSA or PPY.

13 Sensitivity for detecting small nodules and GGOs on MR is poor; CT scan remains the imaging modality

14 mean percentage of total lung classified as GGO was 13.2% and 28.7%, respectively, and was higher th

15 They commonly present as GGO along with vascular thickening, air bronchogram and

16 ulmonologists labeled regions of the lung as GGOs, and the adaptive multiple feature method (AMFM) tr

17 We found no association between %GGO(AMFM) and 1-year FEV(1) decline, but %GGO(AMFM) was

18 earance of COVID-19 pneumonia with bilateral GGO, in peripheral distribution and lower lung zone pred

19 esentations of COP on HRCT include bilateral GGOs and consolidations in the lower lobes together with

20 Notably both GGO and consolidations had a peripheral distribution in

21 Both GGOs and consolidations were revealed more often in the

22 n %GGO(AMFM) and 1-year FEV(1) decline, but %GGO(AMFM) was associated with exacerbations and all-caus

23 ost common finding (30/64, 47%), followed by GGO (21/64, 33%).

24 ed the potential to accurately differentiate GGOs due to COVID-19 pneumonia from those due to other a

25 ased machine learning method to discriminate GGOs due to COVID-19 from those due to other acute lung

26 quantify the volume of the lung with GGOs (%GGO(AMFM)).

27 troglodytes, PTR), gorilla (Gorilla gorilla, GGO) and orangutan (Pongo pygmaeus, PPY).

28 Higher %GGO(AMFM) per interquartile range at visit 1 (baseline)

29 Higher %GGO(AMFM) was cross-sectionally associated with higher W

30 roductive cough were associated with higher %GGO(AMFM).

31 However, GGOs are also seen in other acute lung diseases, thus ma

32 nificant post-COVID sequelae changes include GGO, fibrotic bands, and bronchiectasis.

33 , 6.9 per doubling; P = .001) and increasing GGO attenuation (OR, 3.2; 95% CI: 1.3, 8.3 per standard

34 Indeed GGO were present in 100% of our patients.

35 9 pneumonia were bilateral lung involvement, GGO or mixed (GGO pulse consolidation or reticular) patt

36 s (two of 12, 17%; P = .02; PPV, 85%); mixed GGO, a subtype with GGO in the periphery and a high-atte

37 ules with pure GGO (17 vs 12 lesions), mixed GGO (27 vs 29 lesions), or solid opacity (15 vs 122 lesi

38 Having more mixed GGO with consolidation, pleural effusion, lack of pure G

39 ent, pure ground-glass opacity (GGO), mixed (GGO pulse consolidation or reticular), consolidation, re

40 re bilateral lung involvement, GGO or mixed (GGO pulse consolidation or reticular) patterns, thickene

41 th lymphatic PB predominantly had multifocal GGO with or without a "crazy paving" pattern; identifica

42 pacities and consolidations on CXR, multiple GGO and consolidations on CT scan.

43 hird (n = 9) showed additional small nodular GGOs limited to a single lobe 3-5 days after an initial

44 ver operating characteristic curve (AUCs) of GGO unadjusted and adjusted for demographics were 0.79 a

45 ty (GGO), consolidation opacity, and both of GGO and consolidation were also surveyed based on RT-PCR

46 Severe lymphocytopenia and an extent of GGO >50% on chest CT were independent risk factors for n

47 This was mostly in the form of GGO (58%).

48 a "crazy paving" pattern; identification of GGO should prompt lymphatic workup in this frequently mi

49 The location of GGO correlated with lymphatic imaging and bronchoscopic

50 A significant proportion of GGO correlated with the pathologic processes of diffuse

51 Overall sensitivity and specificity of GGO for lymphatic PB were 91% (32 of 35; 95% CI: 76, 98)

52 Sensitivity and specificity of GGO for lymphatic PB were calculated.

53 Objectives: To assess the association of GGOs with white blood cells (WBCs) and progression of qu

54 The baseline prevalence of GGOs decreased from 100% to 2% of participants at 1 year

55 tent CT changes to include the resolution of GGOs seen in the early recovery phase and the persistenc

56 ression models to assess the association of %GGO(AMFM) with WBCs, changes in percentage emphysema, an

57 CT observations were ground-glass opacities (GGO) (59/70 lobes examined) and areas of consolidation (

58 68-0.82; p < 0.001), ground-glass opacities (GGO) (73%; 95% CI: 0.67-0.78; p < 0.001), and peripheral

59 ritical group, mixed ground-glass opacities (GGO) and consolidation lesion, pleural effusion lesion,

60 mean attenuation of ground glass opacities (GGO) and consolidation were quantified from CT using sem

61 stent indications of ground-glass opacities (GGO), consolidation, and interlobular septal thickening.

62 of the patients had ground-glass opacities (GGO).

63 teral and multilobar ground-glass opacities (GGO).

64 Ground-glass opacities (GGOs) are a non-specific high-resolution computed tomogr

65 Rationale: Ground-glass opacities (GGOs) in the absence of interstitial lung disease are un

66 for the detection of ground-glass opacities (GGOs) were 77.7% and 53.8%, respectively.

67 ning (ILST;100%) and ground glass opacities (GGOs; 91.7%), resulting in crazy-paving pattern (83%).

68 openia or an extent of ground glass opacity (GGO) >50% on chest computed tomography (CT).

69 ndings mainly included ground glass opacity (GGO) (93.3%), inter-lobular septal thickening (66.7%), c

70 rmalities that include ground-glass opacity (GGO) and subpleural bands with concomitant pulmonary fun

71 ng to measure regional ground-glass opacity (GGO) and using inspiratory and expiratory image-matching

72 y high (658/987), with ground-glass opacity (GGO) being the most prevalent feature (52.5%; 95% CI: 40

73 resentation of COP was ground-glass opacity (GGO) in 83.9% of cases, followed by consolidation in 71%

74 location and extent of ground-glass opacity (GGO) was compared with symptoms and lymphatic imaging.

75 bnormal chest CT scan, ground-glass opacity (GGO), consolidation opacity, and both of GGO and consoli

76 features analyzed were ground-glass opacity (GGO), consolidation, pleuroparenchymal band, linear atel

77 us for: consolidation, ground glass opacity (GGO), location and pleural fluid.

78 lung involvement, pure ground-glass opacity (GGO), mixed (GGO pulse consolidation or reticular), cons

79 irspace consolidation, ground-glass opacity (GGO), reticulation, honeycombing, nodules, bronchiectasi

80 and opacity subtypes (ground glass opacity [GGO] and consolidation) were extracted using deep learni

81 Quantitative burden of consolidation or GGO on chest CT independently predict clinical deteriora

82 terstitial pneumonia CT patterns overlapped; GGO was more extensive in patients with nonspecific inte

83 30 patients (nCOVID) showing (a) predominant GGOs pattern on HRCT performed between August 2019 and A

84 CT at hospital admission and (b) predominant GGOs pattern on HRCT; a second set of 30 patients (nCOVI

85 onsolidation, pleural effusion, lack of pure GGO, more diffuse opacity, involvement of more than 2 lo

86 of malignant versus benign nodules with pure GGO (17 vs 12 lesions), mixed GGO (27 vs 29 lesions), or

87 Among nodules with pure GGO, a round shape was found more frequently in malignan

88 Two readers independently segmented GGOs on HRCTs using a semi-automated approach, and radio

89 -0.91; p < 0.001) and higher risk of showing GGO (RR 1.45; 95% CI: 1.13-1.86; p < 0.001).

90 ession confirmed this result by showing that GGO was a significant predictor of lymphatic PB (odds ra

91 Conclusions: Our findings suggest that GGO(AMFM) is associated with increased systemic inflamma

92 ants, we found similar results, except that %GGO(AMFM) was associated with progression to COPD at 1-y

93 eumatoid arthritis-related lung disease were GGO and reticulation.

94 = .02; PPV, 85%); mixed GGO, a subtype with GGO in the periphery and a high-attenuation zone in the

95 els and quantify the volume of the lung with GGOs (%GGO(AMFM)).